Key Highlights
- Approximately 35 million people worldwide have used amphetamines at least once in the past year
- In the United States, about 2 million people aged 12 or older reported using methamphetamine in the past year
- The global methamphetamine market was valued at around $6.4 billion in 2021
- Methamphetamine seizures increased by 7% globally from 2019 to 2020
- The median age of first methamphetamine use in the U.S. is approximately 22 years old
- Approximately 0.3% of the global adult population, or about 22 million people, are estimated to abuse amphetamines
- Amphetamine and methamphetamine use are associated with increased risk of cardiovascular events, according to a study published in the American Journal of Cardiology
- The lifetime prevalence of methamphetamine use among U.S. adults is roughly 2.4%
- Methamphetamine is the second most commonly used illicit stimulant after cocaine in the United States
- The purity of illicit methamphetamine on the street has increased significantly over the past decade, reaching up to 90% purity in some regions
- In a global survey, 3.4% of amphetamine users reported injecting the drug, increasing risks of HIV transmission
- Approximately 15% of individuals seeking treatment for stimulant use disorders in the U.S. are specifically treated for methamphetamine dependence
- The risk of developing psychosis increases among amphetamine users, especially with high doses and prolonged use, as noted in a study in Schizophrenia Research
With over 35 million people worldwide having used amphetamines in the past year, this potent stimulant continues to fuel a global epidemic marked by rising seizures, skyrocketing overdose deaths, and profound health and societal impacts.
Health and Medical Impacts
- Amphetamine and methamphetamine use are associated with increased risk of cardiovascular events, according to a study published in the American Journal of Cardiology
- In a global survey, 3.4% of amphetamine users reported injecting the drug, increasing risks of HIV transmission
- The risk of developing psychosis increases among amphetamine users, especially with high doses and prolonged use, as noted in a study in Schizophrenia Research
- The average daily dose of methamphetamine abused illicitly varies but can reach up to 500 mg or more in some cases
- The neurotoxic effects of methamphetamine may cause long-term damage to dopamine and serotonin neurons, as described in research published in the Journal of Neurochemistry
- Methamphetamine withdrawal symptoms can last for weeks and include fatigue, depression, and increased appetite, according to the National Institute on Drug Abuse
- The rate of methamphetamine overdose deaths in the U.S. increased by over 250% from 2015 to 2021
- In 2022, the prevalence of methamphetamine use disorder among U.S. prisoners was approximately 17%, as per Bureau of Justice Statistics
- In some regions, law enforcement agencies report that methamphetamine is being mixed with caffeine or other substances, complicating treatment and detection
- Approximately 60% of individuals seeking treatment for methamphetamine use report co-occurring mental health disorders, including anxiety and depression
- The long-term economic impact of amphetamine abuse includes increased healthcare costs, law enforcement expenses, and lost productivity, estimated in the billions annually in the U.S.
- A study in Australia indicates that around 45% of amphetamine users who seek treatment eventually relapse within 12 months, highlighting the chronic nature of dependence
- The United Nations Office on Drugs and Crime estimates that approximately 5-10% of all amphetamine users develop dependence, depending on the region and usage patterns
- In 2020, overdose deaths involving methamphetamine in the U.S. reached over 22,000, representing a 45% increase from the previous year
- In 2021, approximately 29% of drug overdose deaths in the U.S. involved methamphetamine, either alone or combined with other substances
- The methamphetamine epidemic has led to an increase in related infectious diseases, including HIV and hepatitis C, especially among injecting users, with infection rates rising by 10% annually in some areas
- The majority of methamphetamine overdose deaths in the U.S. involve concurrent use of opioids such as fentanyl, complicating treatment efforts
- Studies indicate that long-term use of amphetamines can impair cognitive functions such as memory, attention, and decision-making, as documented in neuropsychological research
- Surveys of treatment centers reveal that about 50% of clients dependent on methamphetamine have attempted to quit multiple times without success, indicating high relapse rates
- Data from Europe shows that methamphetamine purity in seizures varies between 40% and 90%, depending on the source, with high-purity batches linked to increased overdose risk
Health and Medical Impacts Interpretation
Law Enforcement and Crime Statistics
- Methamphetamine seizures increased by 7% globally from 2019 to 2020
- The number of amphetamine-related arrests globally decreased slightly in 2020, with around 267,000 arrests documented
- Rural areas in the U.S. have seen a rise in methamphetamine availability, with law enforcement reports indicating a 15% increase in rural seizures over the past five years
- The purity of methamphetamine in stimulants seized in North America has tripled over the last decade, reaching an average of about 90%, according to law enforcement reports
- The use of amphetamines among men convicted of driving under the influence is significantly higher than among women, with estimates around 60% in arrest data
Law Enforcement and Crime Statistics Interpretation
Market Size and Demand
- The global methamphetamine market was valued at around $6.4 billion in 2021
- The global demand for methamphetamine is driven largely by North America, which accounts for over 50% of the consumption
- The average street price of methamphetamine varies widely but generally ranges between $20-$100 per gram depending on purity and location
- The average street price for methamphetamine has decreased in some regions due to increased supply and purity, making it more accessible to new users
Market Size and Demand Interpretation
Prevalence and Usage Patterns
- Approximately 35 million people worldwide have used amphetamines at least once in the past year
- In the United States, about 2 million people aged 12 or older reported using methamphetamine in the past year
- The median age of first methamphetamine use in the U.S. is approximately 22 years old
- Approximately 0.3% of the global adult population, or about 22 million people, are estimated to abuse amphetamines
- The lifetime prevalence of methamphetamine use among U.S. adults is roughly 2.4%
- Methamphetamine is the second most commonly used illicit stimulant after cocaine in the United States
- Approximately 15% of individuals seeking treatment for stimulant use disorders in the U.S. are specifically treated for methamphetamine dependence
- Amphetamine use among adolescents in the U.S. decreased by roughly 7% between 2015 and 2021
- Among those who use methamphetamine, around 10% also report using opioids concurrently, increasing overdose risk
- The average age of first use of amphetamines in Europe is approximately 21 years old, according to European Monitoring Centre for Drugs and Drug Addiction
- Experimental use of amphetamines among college students in the U.S. has declined by about 5% over the last decade, based on Monitoring the Future surveys
- The use of methamphetamine is highest among males aged 18-25 in the U.S., accounting for approximately 70% of cases
- In Asia, particularly in Southeast Asia, methamphetamine is known as "yaba," which is the street name for tablet forms of the drug
- Data shows that regions with higher unemployment rates tend to have increased methamphetamine use, indicating economic factors influence drug consumption patterns
- According to global surveys, about 4% of male youth aged 15-19 have experimented with amphetamines at least once, with higher prevalence in urban areas
- In some countries, amphetamine prescription rates increased during the COVID-19 pandemic, due to increased mental health issues and demand for stimulant medications
- Methamphetamine-related treatment admissions in the U.S. rose by nearly 12% from 2019 to 2022, reflecting increasing prevalence
Prevalence and Usage Patterns Interpretation
Production, Supply, and Economic Factors
- The purity of illicit methamphetamine on the street has increased significantly over the past decade, reaching up to 90% purity in some regions
- The global production of methamphetamine is estimated to be over 600 tons annually, primarily in East Asia and North America
- The majority of illicit methamphetamine in the U.S. is produced in clandestine labs in Mexico, with increasing quantities in recent years
Production, Supply, and Economic Factors Interpretation
Sources & References
- Reference 1UNODCResearch Publication(2024)Visit source
- Reference 2SAMHSAResearch Publication(2024)Visit source
- Reference 3STATISTAResearch Publication(2024)Visit source
- Reference 4CDCResearch Publication(2024)Visit source
- Reference 5AJCONLINEResearch Publication(2024)Visit source
- Reference 6DRUGABUSEResearch Publication(2024)Visit source
- Reference 7SCIENCEDIRECTResearch Publication(2024)Visit source
- Reference 8MONITORINGTHEFUTUREResearch Publication(2024)Visit source
- Reference 9DRUGSResearch Publication(2024)Visit source
- Reference 10JNEUROCHEMResearch Publication(2024)Visit source
- Reference 11BJSResearch Publication(2024)Visit source
- Reference 12EMCDDAResearch Publication(2024)Visit source
- Reference 13NDARCResearch Publication(2024)Visit source
- Reference 14UNICEFResearch Publication(2024)Visit source
- Reference 15WHOResearch Publication(2024)Visit source
- Reference 16JOURNALSResearch Publication(2024)Visit source